S. GÜR Et Al. , "Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment," AGING MALE , vol.23, no.5, pp.1088-1097, 2021
GÜR, S. Et Al. 2021. Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment. AGING MALE , vol.23, no.5 , 1088-1097.
GÜR, S., Alzweri, L., YILMAZ ORAL, D., KAYA SEZGİNER, E., Abdel-Mageed, A. B., Sikka, S. C., ... Hellstrom, W. J. G.(2021). Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment. AGING MALE , vol.23, no.5, 1088-1097.
GÜR, SERAP Et Al. "Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment," AGING MALE , vol.23, no.5, 1088-1097, 2021
GÜR, SERAP Et Al. "Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment." AGING MALE , vol.23, no.5, pp.1088-1097, 2021
GÜR, S. Et Al. (2021) . "Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment." AGING MALE , vol.23, no.5, pp.1088-1097.
@article{article, author={SERAP GÜR Et Al. }, title={Ivabradine, the hyperpolarization-activated cyclic nucleotide-gated channel blocker, elicits relaxation of the human corpus cavernosum: a potential option for erectile dysfunction treatment}, journal={AGING MALE}, year=2021, pages={1088-1097} }